Indeed, the cGAS–STING pathway seems to have a dual role in cancer immunity, both promoting cell growth through modulation of the tumor microenvironment and otherwise activating anti-tumoral inflammatory response, particularly via induction of tumor-specific CD8+ T cells [61,62,63]. This evidence concerns the gene CD8A and neoplasm.